Literature DB >> 23159786

The role of microparticles in the generation of immune complexes in murine lupus.

Anirudh J Ullal1, David S Pisetsky.   

Abstract

Systemic lupus erythematosus is a systemic inflammatory disease characterized by antibodies to nuclear molecules in association with immune complex deposition. As shown previously, microparticles (MPs), which are small membrane-bound vesicles released from dying and activated cells, contain nucleic acids and can form immune complexes found in patient blood. To assess the role of MPs in murine lupus, we used flow cytometry to measure the presence of MPs with bound IgG in the blood of MRL-lpr/lpr and NZB/W mice. These studies showed much higher numbers of MPs with bound IgG in the blood of MRL lpr/lpr compared to NZB/W mice. Furthermore, these studies showed that antibodies from MRL-lpr/lpr mice bound better to MPs from apoptotic cells than those from NZB/W mice. Together, these studies indicate important differences in the serological features of the two strains as reflected by the capacity of antibodies to bind to MPs.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159786      PMCID: PMC3551532          DOI: 10.1016/j.clim.2012.10.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  30 in total

Review 1.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

Review 2.  Microparticles as mediators and biomarkers of rheumatic disease.

Authors:  David S Pisetsky; Anirudh J Ullal; Julie Gauley; Tony C Ning
Journal:  Rheumatology (Oxford)       Date:  2012-03-07       Impact factor: 7.580

3.  Murine lupus strains differentially model unique facets of human lupus serology.

Authors:  L Li; S Nukala; Y Du; J Han; K Liu; J Hutcheson; S Pathak; Q Li; C Mohan
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

Review 4.  Animal models of molecular pathology systemic lupus erythematosus.

Authors:  Allison Sang; Yiming Yin; Ying-Yi Zheng; Laurence Morel
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

5.  Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.

Authors:  F Monneaux; H Dumortier; G Steiner; J P Briand; S Muller
Journal:  Int Immunol       Date:  2001-09       Impact factor: 4.823

Review 6.  Microparticles, vascular function, and atherothrombosis.

Authors:  Pierre-Emmanuel Rautou; Anne-Clémence Vion; Nicolas Amabile; Gilles Chironi; Alain Simon; Alain Tedgui; Chantal M Boulanger
Journal:  Circ Res       Date:  2011-08-19       Impact factor: 17.367

7.  Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.

Authors:  Christoffer T Nielsen; Ole Østergaard; Line Stener; Line V Iversen; Lennart Truedsson; Birgitta Gullstrand; Søren Jacobsen; Niels H H Heegaard
Journal:  Arthritis Rheum       Date:  2012-01-11

Review 8.  Immune responses to DNA in normal and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

Review 9.  Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.

Authors:  Bence György; Tamás G Szabó; Mária Pásztói; Zsuzsanna Pál; Petra Misják; Borbála Aradi; Valéria László; Eva Pállinger; Erna Pap; Agnes Kittel; György Nagy; András Falus; Edit I Buzás
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

10.  Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice.

Authors:  Meera R Krishnan; Congmiao Wang; Tony N Marion
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

View more
  8 in total

Review 1.  Emerging role of extracellular vesicles in inflammatory diseases.

Authors:  Edit I Buzas; Bence György; György Nagy; András Falus; Steffen Gay
Journal:  Nat Rev Rheumatol       Date:  2014-02-18       Impact factor: 20.543

Review 2.  Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases.

Authors:  Melissa Cunningham; Natalia Marks; April Barnado; Jena R Wirth; Gary Gilkeson; Margaret Markiewicz
Journal:  Semin Thromb Hemost       Date:  2014-08-31       Impact factor: 4.180

3.  The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells.

Authors:  Anirudh J Ullal; Tony N Marion; David S Pisetsky
Journal:  Clin Immunol       Date:  2014-05-27       Impact factor: 3.969

Review 4.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

5.  Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2.

Authors:  Anamika Basu; Leanne Woods-Burnham; Greisha Ortiz; Leslimar Rios-Colon; Johnny Figueroa; Roger Albesa; Luis E Andrade; Michael Mahler; Carlos A Casiano
Journal:  Clin Immunol       Date:  2015-07-31       Impact factor: 3.969

Review 6.  Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus.

Authors:  Javier Perez-Hernandez; Raquel Cortes
Journal:  Dis Markers       Date:  2015-09-07       Impact factor: 3.434

7.  Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice.

Authors:  Jürgen Dieker; Luuk Hilbrands; Astrid Thielen; Henry Dijkman; Jo H Berden; Johan van der Vlag
Journal:  Arthritis Res Ther       Date:  2015-04-16       Impact factor: 5.156

Review 8.  Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus.

Authors:  Javier Perez-Hernandez; Josep Redon; Raquel Cortes
Journal:  Int J Mol Sci       Date:  2017-03-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.